Genetic Technologies Limited GENE

$GENE 22% up on ASX

Hairy turtle ? full of crap ?

Just got FDA approval minutes ago.

FDA Approves Oral Treatment for Spinal Muscular Atrophy

The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age and older with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement. This is the second drug and the first oral drug approved to treat this disease.

“Evrysdi is the first drug for this disease that can be taken orally, providing an important treatment option for patients with SMA, following the approval of the first treatment for this devastating disease less than four years ago,” said Billy Dunn, M.D., director of the Office of Neuroscience in the FDA’s Center for Drug Evaluation and Research.

Go for GENE

Natalie
Go for GENE

Check the latest news release on ASX

As per latest announcements
ASX
BNC owns 55.73% of IMC or IMRN

As per latest announcements
ASX
BNC Mellon owns
55.73% of IMC or IMRN

As per latest announcements
ASX
BNC Mellon owns
70.41% GTG or GENE
27.23% of IMM or IMMP
55.73% of IMC or IMRN